2018 Brain Aneurysm Foundation Annual Report 2018-Brain-Aneurysm-Foundation-Annual-Report | Page 6

A WORD FROM . . .
The Executive Director
2018 was another fabulous year of growth and success.
Not only did we award the largest amount of research funding - $500,000, but also, we had our greatest
turnout on Capitol Hill in support of Ellie’s Law. 100 plus people representing the BAF from 20 different
states came together in March to ask their congressmen to support Ellie’s Law – a legislation seeking
$25M for brain aneurysm specific research. Advocacy efforts and funding research go hand in hand,
and great strides are being made!
Because medical education is critical to promoting early detection of brain aneurysms to eliminate
ruptures, the foundation was thrilled to have two live lectures on the diagnosis of brain aneurysms
presented in both Chicago and New York City. The lectures targeted primary care doctors and was
presented to over 1500 practitioners who greatly benefitted from the information. We look forward
to continuing this education with a webcast in 2019.
In the words of Winston Churchill, “Success is not final; failure is not fatal: it is the courage to continue
that counts.” So, no matter the successes to date, there is so much more to be done in the world of
brain aneurysms and their impact on society. Together we will continue our courageous journey until
we live in a world without death and disabilities from brain aneurysm ruptures.
Thank you all for your support in 2018!
Christine J. Buckley
The Medical Advisory Board Executive Director
It is such an honor to serve as the foundation’s Medical Advisory Board Executive Director, and being
a founder, I am completely thrilled with the continued success of this organization each year.
In 2018 we awarded $500,000 to 14 different research projects. This is amazing and is the reason
the foundation is the largest private funder of brain aneurysm research dollars. The research that the
organization funds ranges from discovering the genetic causes of brain aneurysms, developing novel
ways to diagnose brain aneurysms early, determining which patients with an unruptured aneurysm need
treatment, reducing brain injury following rupture, and evaluating the effectiveness of new therapies.
Whether you organized or took part in a local awareness-raising event, established a Chair of Research,
or joined us in Washington for our annual Advocacy Day, we are extremely grateful for your support.
Thanks to you, we are making steady progress toward our shared goal of reducing deaths and
disabilities from brain aneurysms.
Christopher S. Ogilvy, MD
3